Wall Street Analysts Believe Fulcrum Therapeutics (FULC) Could Rally 71.02%: Here's is How to Trade

Fulcrum Therapeutics, Inc. (FULC) closed the last trading session at $9.42, gaining 6.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 16.11 indicates a 71% upside potential. The mean estimate comprises nine short-term price targets with a standard deviation of $5.78. While the lowest estimate of$ 5 indicates a 46.9% decline from the current price level, the most optimistic anal ...